MR imaging of diffuse liver disease. From technique to diagnosis

Radiologic Clinics of North America

Volumn 52, Issue 4, 2014, Pages 709-724

  Hope, Thomas A ^a   Ohliger, Michael A ^a   Qayyum, Aliya ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Diffuse; Fat; Iron; Liver; MR imaging

Indexed keywords

FAT; IRON;

AMYLOIDOSIS; BUDD CHIARI SYNDROME; ELASTOGRAPHY; FATTY LIVER; GLYCOGEN STORAGE DISEASE; HEMOCHROMATOSIS; HUMAN; IMAGE DISPLAY; IRON OVERLOAD; LIPIDOSIS; LIVER CIRRHOSIS; LIVER CONGESTION; LIVER DISEASE; LIVER FIBROSIS; LIVER VENOOCCLUSIVE DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RETICULOENDOTHELIAL SYSTEM; REVIEW; SARCOIDOSIS; WILSON DISEASE;

DIFFUSE; FAT; IRON; LIVER; MR IMAGING;

ADIPOSE TISSUE; CONNECTIVE TISSUE DISEASES; CONTRAST MEDIA; ELASTICITY IMAGING TECHNIQUES; HUMANS; IRON; LIVER DISEASES; MAGNETIC RESONANCE IMAGING; SIGNAL-TO-NOISE RATIO;

EID: 84901640204     PISSN: 00338389     EISSN: 15578275     Source Type: Journal    
DOI: 10.1016/j.rcl.2014.02.016     Document Type: Review

References (37)

1. Sirlin C.B., Reeder S.B. Magnetic resonance imaging quantification of liver iron. Magn Reson Imaging Clin N Am 2010, 18(3):359-381. ix.
2. Gandon Y., Olivié D., Guyader D., et al. Non-invasive assessment of hepatic iron stores by MRI. Lancet 2004, 363(9406):357-362.
3. St Pierre T.G., Clark P.R., Chua-anusorn W., et al. Noninvasive measurement and imaging of liver iron concentrations using proton magnetic resonance. Blood 2005, 105(2):855-861.
4. Wood J.C., Enriquez C., Ghugre N., et al. MRI R2 and R2* mapping accurately estimates hepatic iron concentration in transfusion-dependent thalassemia and sickle cell disease patients. Blood 2005, 106(4):1460-1465.
5. Reeder S.B., Cruite I., Hamilton G., et al. Quantitative assessment of liver fat with magnetic resonance imaging and spectroscopy. JMagn Reson Imaging 2011, 34(4):729-749.
6. Qayyum A., Goh J.S., Kakar S., et al. Accuracy of liver fat quantification at MR imaging: comparison of out-of-phase gradient-echo and fat-saturated fast spin-echo techniques-initial experience. Radiology 2005, 237(2):507-511.
7. Dixon W.T. Simple proton spectroscopic imaging. Radiology 1984, 153(1):189-194.
8. Fishbein M.H., Gardner K.G., Potter C.J., et al. Introduction of fast MR imaging in the assessment of hepatic steatosis. Magn Reson Imaging 1997, 15(3):287-293.
9. Reeder S.B., Hu H.H., Sirlin C.B. Proton density fat-fraction: a standardized mr-based biomarker of tissue fat concentration. JMagn Reson Imaging 2012, 36(5):1011-1014.
10. Hernando D., Kramer J.H., Reeder S.B. Multipeak fat-corrected complex R2* relaxometry: theory, optimization, and clinical validation. Magn Reson Med 2013, 70(5):1319-1331.
11. Kühn J.P., Hernando D., Munoz Del Rio A., et al. Effect of multipeak spectral modeling of fat for liver iron and fat quantification: correlation of biopsy with MR imaging results. Radiology 2012, 265(1):133-142.
12. Bydder M., Yokoo T., Hamilton G., et al. Relaxation effects in the quantification of fat using gradient echo imaging. Magn Reson Imaging 2008, 26(3):347-359.
13. Yu H., Shimakawa A., McKenzie C.A., et al. Multiecho water-fat separation and simultaneous R2* estimation with multifrequency fat spectrum modeling. Magn Reson Med 2008, 60(5):1122-1134.
14. Venkatesh S.K., Yin M., Ehman R.L. Magnetic resonance elastography of liver: technique, analysis, and clinical applications. JMagn Reson Imaging 2013, 37(3):544-555.
15. Girometti R., Furlan A., Bazzocchi M., et al. Diffusion-weighted MRI in evaluating liver fibrosis: a feasibility study in cirrhotic patients. Radiol Med 2007, 112(3):394-408.
16. Yin M., Talwalkar J.A., Glaser K.J., et al. Assessment of hepatic fibrosis with magnetic resonance elastography. Clin Gastroenterol Hepatol 2007, 5(10):1207-1213.e2.
17. Wang Y., Ganger D.R., Levitsky J., et al. Assessment of chronic hepatitis and fibrosis: comparison of MR elastography and diffusion-weighted imaging. Am J Roentgenol 2011, 196(3):553-561.
18. Rustogi R., Horowitz J., Harmath C., et al. Accuracy of MR elastography and anatomic MR imaging features in the diagnosis of severe hepatic fibrosis and cirrhosis. JMagn Reson Imaging 2012, 35(6):1356-1364.
19. International Working Party Terminology of nodular hepatocellular lesions. Hepatology 1995, 22(3):983-993.
20. International Consensus Group for Hepatocellular NeoplasiaThe International Consensus Group for Hepatocellular Neoplasia Pathologic diagnosis of early hepatocellular carcinoma: a report of the international consensus group for hepatocellular neoplasia. Hepatology 2009, 49(2):658-664.
21. Jeong Y.Y., Yim N.Y., Kang H.K. Hepatocellular carcinoma in the cirrhotic liver with helical CT and MRI: imaging spectrum and pitfalls of cirrhosis-related nodules. Am J Roentgenol 2005, 185(4):1024-1032.
22. Kogita S., Imai Y., Okada M., et al. Gd-EOB-DTPA-enhanced magnetic resonance images of hepatocellular carcinoma: correlation with histological grading and portal blood flow. Eur Radiol 2010, 20(10):2405-2413.
23. Chen J., Talwalkar J.A., Yin M., et al. Early detection of nonalcoholic steatohepatitis in patients with nonalcoholic fatty liver disease by using MR elastography. Radiology 2011, 259(3):749-756.
24. Hamer O.W., Aguirre D.A., Casola G., et al. Fatty liver: imaging patterns and pitfalls. Radiographics 2006, 26(6):1637-1653.
25. Schwenzer N.F., Machann J., Haap M.M., et al. T2* relaxometry in liver, pancreas, and spleen in a healthy cohort of one hundred twenty-nine subjects-correlation with age, gender, and serum ferritin. Invest Radiol 2008, 43(12):854-860.
26. Kozic D., Svetel M., Petrovic I., et al. Regression of nodular liver lesions in Wilson's disease. Acta Radiol 2006, 47(7):624-627.
27. Ko S., Lee T., Ng S., et al. Unusual liver MR findings of Wilson's disease in an asymptomatic 2-year-old girl. Abdom Imaging 1998, 23(1):56-59.
28. Manzia T.M., Angelico R., Toti L., et al. Glycogen storage disease type Ia and VI associated with hepatocellular carcinoma: two case reports. Transplant Proc 2011, 43(4):1181-1183.
29. Shanbhogue A., Shah S., Zaheer A., et al. Hepatocellular adenomas: current update on genetics, taxonomy, and management. JComput Assist Tomogr 2011, 35(2):159-166.
30. Roser W., Beckmann N., Wiesmann U., et al. Absolute quantification of the hepatic glycogen content in a patient with glycogen storage disease by 13C magnetic resonance spectroscopy. Magn Reson Imaging 1996, 14(10):1217-1220.
31. Ouwerkerk R., Pettigrew R.I., Gharib A.M. Liver metabolite concentrations measured with 1H MR spectroscopy. Radiology 2012, 265(2):565-575.
32. Merlini G., Seldin D.C., Gertz M.A. Amyloidosis: pathogenesis and new therapeutic options. JClin Oncol 2011, 29(14):1924-1933.
33. Ferreira A., Ramalho M., de Campos R.O., et al. Hepatic sarcoidosis: MR appearances in patients with chronic liver disease. Magn Reson Imaging 2013, 31(3):432-438.
34. Janssen H.L., Garcia-Pagan J.C., Elias E., et al. Budd-Chiari syndrome: a review by an expert panel. JHepatol 2003, 38(3):364-371.
35. Brancatelli G., Vilgrain V., Federle M.P., et al. Budd-Chiari syndrome: spectrum of imaging findings. Am J Roentgenol 2007, 188(2):W168-W176.
36. Rubbia-Brandt L. Sinusoidal obstruction syndrome. Clin Liver Dis 2010, 14(4):651-668.
37. Shin N.Y., Kim M.J., Lim J.S., et al. Accuracy of gadoxetic acid-enhanced magnetic resonance imaging for the diagnosis of sinusoidal obstruction syndrome in patients with chemotherapy-treated colorectal liver metastases. Eur Radiol 2012, 22(4):864-871.